AI is revolutionizing the drug design process by using machine learning and data analysis to quickly identify promising compounds, accelerate validation of drug targets,…
Browsing: Drug Development
CluePoints, a company specializing in risk-based quality management tools and software, will be unveiling two new products at the upcoming DIA conference in San…
BioXcel Therapeutics utilizes big data and machine learning algorithms to repurpose drugs for new indications, reducing the time and cost of drug development.
AstraZeneca, a British-Swedish pharmaceutical and biotechnology giant, has deeply ingrained data science and AI capabilities throughout its drug development lifecycle. The company has implemented…
Intrepid Lab’s AI-driven platform is revolutionizing drug development by drastically reducing costs and improving success rates. Co-founder Christine Allen, with 25 years in drug…
The global healthcare cloud computing market is projected to reach $131.8 billion by 2031, growing at a CAGR of 18.4% from 2024 to 2031.…
LabGenius, a UK drug discovery startup, has raised £35m in funding to further develop their machine learning-driven platform for creating antibody therapies to treat…
The pharmaceutical industry is constantly evolving and AI has the potential to make a significant impact in drug development. With the release of ChatGPT…
Tala Fakhouri, Associate Director for Policy Analysis at the FDA, discusses the use of artificial intelligence and machine learning in drug development. She highlights…
Dr Ashok Kumar, President-CRD, IPCALaboratories, discusses the impact of AI in scientific research and drug development, highlighting its potential to revolutionize complex tasks and…